A susceptibility result can shift before the organism changes. That is why MUELLER HINTON II Broth Culture Media must be considered together with inoculum, atmosphere, incubation, and endpoint reading. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 620218 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.
Analytical scope and method role
Liquid medium for quantitative antimicrobial susceptibility testing of rapidly growing aerobic organisms by broth dilution procedures, as standardized by the CLSI.
Method principle
Acid hydrolysate of casein and beef extract provide amino acids, nitrogen, minerals, vitamins, carbon and other nutrients which support the growth of microorganisms. These ingredients are selected for low thymine and thymidine content as determined by MIC values obtained by testing Enterococcus faecalis with trimethoprim-sulfamethoxazole (SXT). Starch acts as a protective colloid against toxic molecules which can be present in the medium. Hydrolysis of starch during autoclaving supplies a little amount of glucose, which is a source of energy. Specified levels of calcium and magnesium are based on studies performed with aminoglycosides and Pseudomonas aeruginosa. Broth dilution methods, macrodilution and microdilution, are used to measure quantitatively the in vitro activity of an antimicrobial agent against a given bacterial isolate.
Formula and functional interpretation
* (g/l) Beef Extract 3.0 Acid Hydrolysate of Casein 17.5 Starch 1.5 Final pH 7.3 ± 0.1 at 25°C *Adjusted and/or supplemented as required with appropriate salts to provide the following concentrations of ions and meet
Review the nutritive, selective, differential, buffering, reducing, and indicator components against the expected target and background flora. Preparation errors can change recovery, inhibition, colour development, or endpoint visibility even when incubation is correct.
Preparation and execution: controlled method points
Preparation: Dehydrated medium Suspend 22 g of the powder in 1 liter of distilled or deionized water. Mix well. Heat to boil shaking frequently until completely dissolved. Sterilize in autoclave at 121°C for 10 minutes.
Procedure: 1. Prepare antimicrobial agents in serial two-fold dilutions in Mueller Hinton II Broth. © Liofilchem - Mueller Hinton II Broth - Rev.4 / 16.12.2022 Page 2 of 7 2. Prepare a standardized suspension of the test organism using either the direct colony suspension or growth method. 3. Add the suitable volume of the adjusted inoculum to each tube/well containing the antimicrobial agent in the dilution series, and mix. 4. Incubate the tubes or trays aerobically at 35 ± 2°C for 16-20 hours. For more detailed information, consult appropriate guidance.
Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.
Quality control: what the control result protects
organisms. SPECIMENS Specimens should be obtained before antimicrobial therapy (where possible) and promptly delivered to the laboratory for examination. Clinical samples are not inoculated directly onto MH II broth. The microorganism to be tested must first be isolated on a nonselective solid medium, such as blood agar or tryptic soy agar (TSA). Refer to specific guidelines for more detailed information.
Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.
Interpretation and confirmation pathway
After incubation the presence of turbidity indicates growth of the organism. The lowest concentration of antimicrobial agent showing no growth is the MIC of that organism for that agent. Interpret the MIC by referring to the current CLSI document M100 and report the organism as susceptible, intermediate or resistant to the agents that have been tested.
Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.
Storage, stability, and pre-use inspection
The powder is very hygroscopic, store the powder at 10-30°C, in a dry environment, in its original container tightly closed. Store tubes and bottles at 10-25°C away from light. Do not use the product beyond its expiry date on the label or if product shows any evidence of contamination or any sign of deterioration.
Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.
Limitations and boundaries of use
Invalid results can be caused by poor specimen quality, improper sample collection, improper transportation, improper laboratory processing, or a limitation of the testing technology. The operator should understand the principles of the procedures, including its
Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.
Troubleshooting from evidence, not guesswork
- Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
- Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
- Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
- Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.
External method context
The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.
External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.
EUCAST disk diffusion and quality control
EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.
FDA Bacteriological Analytical Manual
FDA BAM methods organize food microbiology around validated sampling, preparation, enrichment, isolation, and confirmation steps, with method applicability tied to the matrix and target organism. Sampling uncertainty, homogenization efficiency, inhibitory ingredients, dilution design, and countable range can dominate the result before the culture medium is ever inoculated; those variables belong in method verification and uncertainty review. Review the authoritative source.
WHO Laboratory Quality Management System handbook
WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.
Technical references
- Manufacturer product documentation for catalogue 620218.
- EUCAST disk diffusion and quality control (access checked 2026-07-20).
- FDA Bacteriological Analytical Manual (access checked 2026-07-20).
- WHO Laboratory Quality Management System handbook (access checked 2026-07-20).
Bench-use checklist
- Verify product identity, catalogue number, lot, expiry, and storage history.
- Document preparation and incubation exactly as controlled in the SOP.
- Define controls and acceptance criteria before testing.
- Record raw observations, control response, reading time, and confirmation decision.
- Escalate failed controls, atypical reactions, and departures through the quality system.